Delivery Order SPE2DB25D7056-SPE2DB25FTLVB

Award Date 1/14/25
Potential Completion Date 1/15/25
Potential Value $3.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the ROTATEQ vaccine, a rotavirus vaccine, in 2 milliliter vials. The contract has a total ceiling value of $1,300.85 and a period of performance through August 27, 2024. The contract is a firm-fixed price type and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the ROTATEQ vaccine in 2 ml vials. The contract has a total ceiling value of $1,009.64 and runs through August 2, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen, through its Corporate Office division, will provide these critical vaccine supplies to support military treatment...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the ROTATEQ vaccine. The contract has a ceiling value of $3,433.43 and an ultimate completion date of October 18, 2024. The contract type is firm fixed price. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,559,107,429 units of the ROTATEQ vaccine in 2 mL vials. The $2,613.32 contract has a completion date of November 16, 2022 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $1,576.59 contract is for the delivery of ROTATEQ vaccine 2ML to support military treatment programs and facilities. The order is part of an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,249.56 firm-fixed-price contract is for the supply of the ROTATEQ vaccine in 2 ml doses. The contract has an ultimate completion date of September 3, 2024 and does not have a set-aside designation. Amerisourcebergen has been awarded multiple Indefinite Delivery Contracts (IDCs) by DLA Troop Support Medical and the Department of Justice Federal...
This $2,605.24 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of 4,565,164,820 units of the ROTATEQ vaccine. The order has a completion date of July 17, 2024 and is not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,664.10, is a delivery order for the ROTATEQ vaccine in 2 milliliter vials. The contract has an ultimate completion date of January 28, 2025 and uses a firm fixed price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,102.58 firm fixed-price delivery order is for the ROTATEQ vaccine, a vaccine for the prevention of rotavirus gastroenteritis in children. The contract has an ultimate completion date of November 21, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,610.05, is for the delivery of the ROTATEQ vaccine in 2-milliliter doses. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
  • SPE2DB25D7056
    Indefinite Delivery Contract
  • SPE2DB25D7056-SPE2DB25FTLVB
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,885.60, is for the delivery of the ROTATEQ vaccine, a 2-milliliter dosage. The contract has an ultimate completion date of January 15, 2025. This contract is part of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/16/25, 5:56 PM